McKesson Corporation (MCK) stock analysis
MCK · McKesson Corporation
Latest recorded price: USD 1,105.31
Model-estimated fair value: USD 986.89. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Distribution
At $1,105.31, MCK trades 12.0% above the model's base-case value of $986.89. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $740.61 in the conservative case and $1,286.93 in the optimistic case, with a valuation confidence score of 78/100. Fiscal 2026 figures: revenue growth 13.4%, free cash flow margin 1.4%. The model does not flag any risk signals for this company.
Similar companies in Healthcare
- Cardinal Health, Inc. (CAH)
- Cencora, Inc. Common Stock (COR)
- Henry Schein, Inc. - Common Stock (HSIC)
- Madrigal Pharmaceuticals, Inc. - Common Stock (MDGL)
- Medtronic plc. Ordinary Shares (MDT)
- Medpace Holdings, Inc. - Common Stock (MEDP)
- MeiraGTx Holdings plc (MGTX)
- Mirum Pharmaceuticals, Inc. - common stock (MIRM)